Skip to search formSkip to main contentSkip to account menu

5-methylpyrazole-3-carboxylic acid

Known as: 3-methylpyrazole-5-carboxylic acid 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

AS 057278

Broader (1)

Pyrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Notwendigkeit von Glucose zur Langzeitblockierung der Lipolyse mit 3,5-Dimethylisoxazol und 5-Methylpyrazol-3-Carbonsäure
ZusammenfassungDurch isolierte Dauerinfusion von Äthylalkohol 1,4 g/Tag über 4 Tage entsteht bei der weiblichen Wistar-Ratte… 
1982
1982
Effects of adrenaline on ketogenesis from long- and medium-chain fatty acids in starved rats.
1. Injection of adrenaline into 24 h-starved rats caused a 69% decrease in blood [ketone-body] (3-hydroxybutyrate plus… 
1981
1981
[Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives. Identification and lipolysis inhibitory activity (author's transl)].
5-Methylpyrazole-3-carboxylic acid forms salts with basically substituted adenine bases of type (4) or (5), which have… 
1975
1975
[Effect of methylpyrazole-carboxylic acid on carbohydrate and lipid metabolisms in patients with diabetes mellitus].
The effect of 3-methylpyrazole-5-carboxylic acid (MPC) on carbohydrate and lipid metabolisms was studied in 18 patients with… 
1972
1972
[Behavior of carbohydrate and lipid metabolism parameters and of 11-hydroxycorticoids in insulin-needing diabetics under long-term therapy using 5-methylpyrazole-3-carboxylic acid].
1971
1971
The effect of nicotinic acid, 5-methylpyrazole-3-carboxylic acid (U-19425), and dibutyryl cyclic AMP on renal gluconeogenesis.
The effects of nicotinic acid, 5-methylpyrazole-3-carboxylic acid (U-19425), and dibutyryl (DB-) cyclic AMP on gluconeogenesis… 
1970
1970
Stimulation of lipolysis in adipose tissue in vitro by inhibitors of lipid mobilization.
5-Methylpyrazole-3-carboxylic acid (U-19425) and nicotinic acid, which apparently inhibit lipolysis in vivo as indicated by low… 
1967
1967
Development of Tachyphylaxis to the Antilipolytic, Hypoglycemic Agent, 5-Methylpyrazole-3-carboxylic Acid, U-19425.∗
Summary After 4 days of treatment with U-19425, rats no longer respond to the drug with a decrease in plasma FFA and blood sugar… 
1965
1965
5-METHYLPYRAZOLE-3-CARBOXYLIC ACID. THE POTENT HYPOGLYCEMIC METABOLITE OF 3,5-DIMETHYLPYRAZOLE IN THE RAT.